2013 Q4 Form 10-Q Financial Statement
#000114420413059215 Filed on November 06, 2013
Income Statement
| Concept | 2013 Q4 | 2013 Q3 | 2012 Q3 |
|---|---|---|---|
| Revenue | $880.0K | $880.7K | $605.3K |
| YoY Change | 46.67% | 45.49% | |
| Cost Of Revenue | $840.0K | $620.6K | $141.8K |
| YoY Change | 1300.0% | 337.52% | |
| Gross Profit | $40.00K | $260.1K | $463.5K |
| YoY Change | -92.73% | -43.89% | |
| Gross Profit Margin | 4.55% | 29.53% | 76.57% |
| Selling, General & Admin | $1.010M | $687.8K | $359.6K |
| YoY Change | 48.53% | 91.25% | -20.08% |
| % of Gross Profit | 2525.0% | 264.46% | 77.59% |
| Research & Development | $30.00K | $294.2K | $554.3K |
| YoY Change | -95.59% | -46.92% | -28.94% |
| % of Gross Profit | 75.0% | 113.12% | 119.58% |
| Depreciation & Amortization | $10.00K | $20.00K | $10.00K |
| YoY Change | -50.0% | 100.0% | -50.0% |
| % of Gross Profit | 25.0% | 7.69% | 2.16% |
| Operating Expenses | $1.040M | $1.140M | $1.065M |
| YoY Change | -23.53% | 7.07% | -13.44% |
| Operating Profit | -$1.000M | -$879.8K | -$601.2K |
| YoY Change | 23.46% | 46.35% | -51.12% |
| Interest Expense | -$120.0K | -$84.95K | -$50.80K |
| YoY Change | 0.0% | 67.21% | -89.84% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$84.95K | -$50.80K | |
| YoY Change | 67.21% | ||
| Pretax Income | -$1.130M | -$964.8K | -$652.0K |
| YoY Change | 21.51% | 47.98% | -62.31% |
| Income Tax | -$460.0K | ||
| % Of Pretax Income | |||
| Net Earnings | -$670.0K | -$964.8K | -$652.0K |
| YoY Change | 24.07% | 47.98% | -62.31% |
| Net Earnings / Revenue | -76.14% | -109.55% | -107.7% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$67.88K | -$98.97K | -$79.46K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 245.1M shares | 245.1M shares | 203.0M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2013 Q4 | 2013 Q3 | 2012 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $2.200M | $2.300M | $2.100M |
| YoY Change | 29.41% | 9.52% | -8.7% |
| Cash & Equivalents | $2.183M | $2.350M | $2.061M |
| Short-Term Investments | |||
| Other Short-Term Assets | $600.0K | $700.0K | $100.0K |
| YoY Change | 20.0% | 600.0% | |
| Inventory | $245.6K | $362.5K | $600.0K |
| Prepaid Expenses | |||
| Receivables | $500.0K | $200.0K | $100.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $3.487M | $3.644M | $2.900M |
| YoY Change | 18.62% | 25.66% | 16.0% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $144.4K | $143.5K | $100.0K |
| YoY Change | -0.83% | 43.53% | 0.0% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $414.4K | $251.4K | $300.0K |
| YoY Change | 63.0% | -16.2% | 0.0% |
| Total Long-Term Assets | $558.8K | $394.9K | $400.0K |
| YoY Change | 39.75% | -1.26% | 0.0% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $3.487M | $3.644M | $2.900M |
| Total Long-Term Assets | $558.8K | $394.9K | $400.0K |
| Total Assets | $4.046M | $4.039M | $3.300M |
| YoY Change | 21.15% | 22.39% | 13.79% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $786.5K | $572.0K | $700.0K |
| YoY Change | -1.77% | -18.28% | -12.5% |
| Accrued Expenses | $400.0K | $500.0K | $400.0K |
| YoY Change | 33.33% | 25.0% | -33.33% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $1.600M | $1.600M | $1.000M |
| YoY Change | 77.78% | 60.0% | 400.0% |
| Total Short-Term Liabilities | $3.065M | $3.066M | $2.100M |
| YoY Change | 47.58% | 45.99% | 31.25% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.065M | $3.066M | $2.100M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $3.065M | $3.066M | $2.100M |
| YoY Change | 47.58% | 45.99% | 16.67% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$105.8M | ||
| YoY Change | |||
| Common Stock | $10.05K | $245.1K | |
| YoY Change | -95.32% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$14.27M | -$13.61M | $1.200M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $4.046M | $4.039M | $3.300M |
| YoY Change | 21.15% | 22.39% | 13.79% |
Cashflow Statement
| Concept | 2013 Q4 | 2013 Q3 | 2012 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$670.0K | -$964.8K | -$652.0K |
| YoY Change | 24.07% | 47.98% | -62.31% |
| Depreciation, Depletion And Amortization | $10.00K | $20.00K | $10.00K |
| YoY Change | -50.0% | 100.0% | -50.0% |
| Cash From Operating Activities | -$1.100M | -$560.0K | -$630.0K |
| YoY Change | 42.86% | -11.11% | -42.73% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$170.0K | -$10.00K | $10.00K |
| YoY Change | 750.0% | -200.0% | -150.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | ||
| YoY Change | |||
| Cash From Investing Activities | -$170.0K | -$10.00K | $10.00K |
| YoY Change | 750.0% | -200.0% | -150.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.180M | 1.010M | 950.0K |
| YoY Change | 156.52% | 6.32% | |
| NET CHANGE | |||
| Cash From Operating Activities | -1.100M | -560.0K | -630.0K |
| Cash From Investing Activities | -170.0K | -10.00K | 10.00K |
| Cash From Financing Activities | 1.180M | 1.010M | 950.0K |
| Net Change In Cash | -90.00K | 440.0K | 330.0K |
| YoY Change | -72.73% | 33.33% | -129.46% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.100M | -$560.0K | -$630.0K |
| Capital Expenditures | -$170.0K | -$10.00K | $10.00K |
| Free Cash Flow | -$930.0K | -$550.0K | -$640.0K |
| YoY Change | 24.0% | -14.06% | -40.74% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| ctso |
Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
|
USD | ||
| ctso |
Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
|
USD | ||
| ctso |
Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
|
278087 | USD | |
| CY2012Q4 | ctso |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
349841 | USD |
| CY2013Q3 | ctso |
Agreement To Purchase Shares Value
AgreementToPurchaseSharesValue
|
8500000 | USD |
| ctso |
Agreement To Purchase Shares Value During Period
AgreementToPurchaseSharesValueDuringPeriod
|
50000 | USD | |
| ctso |
Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
|
USD | ||
| ctso |
Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
|
USD | ||
| CY2013Q3 | ctso |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
496443 | USD |
| ctso |
Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
|
3351961 | USD | |
| ctso |
Consulting Fees
ConsultingFees
|
USD | ||
| ctso |
Consulting Fees
ConsultingFees
|
USD | ||
| ctso |
Consulting Fees
ConsultingFees
|
237836 | USD | |
| CY2013Q3 | ctso |
Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
|
281424 | USD |
| CY2012Q4 | ctso |
Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
|
178775 | USD |
| ctso |
Debt Discount
DebtDiscount
|
331117 | USD | |
| ctso |
Debt Discount
DebtDiscount
|
87700 | USD | |
| ctso |
Debt Discount
DebtDiscount
|
1975322 | USD | |
| ctso |
Debt Instrument Maturity Period
DebtInstrumentMaturityPeriod
|
P1Y | ||
| CY2013Q2 | ctso |
Debt Instrument Maturity Period
DebtInstrumentMaturityPeriod
|
P1Y | |
| CY2013Q3 | ctso |
Debt Instrument Percent Of Principal Amount
DebtInstrumentPercentOfPrincipalAmount
|
0.5 | pure |
| ctso |
Dividends Preferred Stock Seriesa Shares
DividendsPreferredStockSeriesaShares
|
122579 | shares | |
| ctso |
Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
|
-1716084 | USD | |
| ctso |
Dividends Preferred Stock Series B Shares
DividendsPreferredStockSeriesBShares
|
5526.50 | shares | |
| ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Shares
IssuanceOfCommonStockInExchangeForConvertibleNotesShares
|
9739912 | shares | |
| ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
1226042 | USD | |
| ctso |
Management Units Issued
ManagementUnitsIssued
|
USD | ||
| ctso |
Management Units Issued
ManagementUnitsIssued
|
USD | ||
| ctso |
Management Units Issued
ManagementUnitsIssued
|
437206 | USD | |
| ctso |
Supplemental Noncash Transactions
SupplementalNoncashTransactions
|
768063 | USD | |
| ctso |
Technology And Content Expense
TechnologyAndContentExpense
|
USD | ||
| ctso |
Technology And Content Expense
TechnologyAndContentExpense
|
USD | ||
| ctso |
Technology And Content Expense
TechnologyAndContentExpense
|
4550000 | USD | |
| ctso |
Warrant Exercise Price
WarrantExercisePrice
|
0.10 | ||
| CY2013Q2 | ctso |
Warrant Exercise Price
WarrantExercisePrice
|
0.15 | |
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| CY2013Q3 | ctso |
Number Of Patents Issued
NumberOfPatentsIssued
|
32 | pure |
| ctso |
Period In Which Certain Amount Of Stock Can Be Sold
PeriodInWhichCertainAmountOfStockCanBeSold
|
P2D | ||
| ctso |
Period In Which Common Stock Can Be Sold
PeriodInWhichCommonStockCanBeSold
|
P32M | ||
| ctso |
Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
|
1728053 | USD | |
| ctso |
Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
|
1870846 | USD | |
| ctso |
Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
|
12650088 | USD | |
| CY2013Q3 | ctso |
Preferred Stock Value Not Included In Stockholders Equity
PreferredStockValueNotIncludedInStockholdersEquity
|
14583515 | USD |
| CY2012Q4 | ctso |
Preferred Stock Value Not Included In Stockholders Equity
PreferredStockValueNotIncludedInStockholdersEquity
|
12887817 | USD |
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeited In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue
|
0.06 | ||
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeituresInPeriod
|
2035000 | shares | |
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Granted In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantedInPeriodWeightedAverageGrantDateFairValue
|
0.03 | ||
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriod
|
13985000 | shares | |
| CY2013Q3 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
|
13418000 | shares |
| CY2012Q4 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
|
7394000 | shares |
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriod
|
5926000 | shares | |
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
0.05 | ||
| CY2013Q3 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
|
0.03 | |
| CY2012Q4 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
|
0.05 | |
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
|
2235000 | shares | |
| CY2013Q3 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableAggregateIntrinsicValue
|
842000 | USD |
| ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantedInPeriodWeightedAverageRemainingContractualTerm
|
P5Y9M18D | ||
| CY2013Q3 | ctso |
Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y4M24D | |
| CY2012Q4 | ctso |
Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M6D | |
| ctso |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
139527 | USD | |
| ctso |
Supplemental Noncash Transactions
SupplementalNoncashTransactions
|
USD | ||
| ctso |
Supplemental Noncash Transactions
SupplementalNoncashTransactions
|
USD | ||
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2939588 | USD |
| CY2013Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
394942 | USD |
| CY2012Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
399820 | USD |
| us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>1. BASIS OF PRESENTATION</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.5in"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q of the Securities and Exchange Commission (the "Commission") and include the results of CytoSorbents Corporation (the "Parent"), CytoSorbents, Inc., its wholly-owned operating subsidiary (the "Subsidiary"), and CytoSorbents Europe GmbH, its wholly-owned European subsidiary (the "European Subsidiary"), collectively referred to as "the Company." Accordingly, certain information and footnote disclosures required in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. Interim statements are subject to possible adjustments in connection with the annual audit of the Company's accounts for the year ended December 31, 2013. In the opinion of the Company's management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) which the Company considers necessary for the fair presentation of the Company's consolidated financial position as of September 30, 2013 and the results of its operations and cash flows for the nine and three month periods ended September 30, 2013 and 2012, and for the period January 22, 1997 (date of inception) to September 30, 2013. Results for the nine and three months ended are not necessarily indicative of results that may be expected for the entire year. The unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company and the notes thereto as of and for the year ended December 31, 2012 as included in the Company's Form 10-K filed with the Commission on April 03, 2013.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has experienced negative cash flows from operations since inception and has a deficit accumulated during the development stage at September 30, 2013 of $104,469,233 The Company is not currently generating significant revenue and is dependent on the proceeds of present and future financings to fund its research, development and commercialization program. These matters raise substantial doubt about the Company's ability to continue as a going concern. The Company is continuing its fund-raising efforts. Although the Company has historically been successful in raising additional capital through equity and debt financings, there can be no assurance that the Company will be successful in raising additional capital in the future or that it will be on favorable terms. We believe that we have sufficient cash to fund our operations into the second quarter of 2014, following which we will need additional funding before we can complete additional clinical studies and continue to commercialize our products. Furthermore, if the Company is successful in raising the additional financing, there can be no assurance that the amount will be sufficient to complete the Company's plans. These consolidated financial statements do not include any adjustments related to the outcome of this uncertainty.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company is a development stage company and has not yet generated significant revenues from inception to September 30, 2013. Since inception, the Company's expenses relate primarily to research and development, organizational activities, clinical manufacturing, regulatory compliance, sales and operational strategic planning. Although the Company has made advances on these matters, there can be no assurance that the Company will continue to be successful regarding these issues, nor can there be any assurance that the Company will successfully implement its long-term strategic plans.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company has developed an intellectual property portfolio, including 32 issued U.S. patents, and multiple pending patents, covering materials, methods of production, systems incorporating the technology and multiple medical uses.</p> <table style="FONT: 10pt Times New Roman, Times, Serif; WIDTH: 100%" cellspacing="0" cellpadding="0"> <tr> <td style="TEXT-ALIGN: center; WIDTH: 100%"> </td> </tr> <tr> <td> </td> </tr> </table> <!--EndFragment--></div> </div> | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-09-30 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
420506 | USD | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
2694197 | USD | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
USD | ||
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
USD | ||
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
183556 | USD | |
| us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
331117 | USD | |
| CY2013Q3 | us-gaap |
Assets
Assets
|
4039006 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
3339408 | USD |
| CY2013Q3 | us-gaap |
Assets Current
AssetsCurrent
|
3644064 | USD |
| dei |
Entity Registrant Name
EntityRegistrantName
|
Cytosorbents Corp | ||
| CY2013Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
245140613 | shares |
| dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001175151 | ||
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
228468 | USD | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
300105 | USD | |
| dei |
Trading Symbol
TradingSymbol
|
csto | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
300000 | USD | |
| CY2013Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
| CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
| us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
533648 | USD | |
| CY2013Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
572014 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
800670 | USD |
| CY2013Q3 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
193873 | USD |
| CY2012Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
51779 | USD |
| CY2013Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
24253 | USD |
| CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-12662 | USD |
| CY2013Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
90587894 | USD |
| CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
86903415 | USD |
| us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
USD | ||
| us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
USD | ||
| CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2349994 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1729344 | USD |
| CY2012Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2061132 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1186653 | USD |
| CY1997Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
620650 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
874479 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2349994 | USD | |
| CY2013Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
26437617 | shares |
| us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
13175491 | USD | |
| CY2013Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
800000000 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
245140613 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
214967503 | shares |
| CY2013Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
245140613 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
214967503 | shares |
| CY2013Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
245141 | USD |
| CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
214968 | USD |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3971805 | USD | |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3125886 | USD | |
| CY2013Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-924605 | USD |
| CY2012Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-651980 | USD |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-91794892 | USD | |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Concentration of Credit Risk</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company maintains cash balances, at times, with financial institutions in excess of amounts insured by the Federal Deposit Insurance Corporation. Management monitors the soundness of these institutions in an effort to minimize its collection risk of these balances.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> As of September 30, 2013, three customers (one U.S. government grant agency, one distributor, and one direct hospital customer) accounted for approximately 73 percent of outstanding accounts receivable. At December 31, 2012, accounts receivable consisted of five direct hospital customers who in the aggregate represented 100% of outstanding accounts receivable, each of whom individually had more than 10 percent of outstanding accounts receivable. For the nine months ended September 30, 2013, approximately 67.1 percent of revenues were from two U.S. government grant agencies, and no other agency, distributor, or direct customer represented more than 10% of the Company's revenue. For the nine months ended September 30, 2012, approximately 91 percent of revenue was from two U.S. government grant agencies, each of whom individually comprised more than 10 percent of the Company's total revenue.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong> </strong></p> <!--EndFragment--></div> </div> | ||
| us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
USD | ||
| us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
USD | ||
| us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
559 | USD | |
| us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
USD | ||
| us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
USD | ||
| us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
399395 | USD | |
| CY2013Q3 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
1511883 | USD |
| CY2012Q3 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
612300 | USD |
| CY2013Q3 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
1562000 | USD |
| CY2012Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
926225 | USD |
| CY2013Q3 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1561576 | USD |
| CY2012Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
926225 | USD |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1073689 | USD | |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
261101 | USD | |
| CY2013Q3 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
620623 | USD |
| CY2012Q3 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
141849 | USD |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1907560 | USD | |
| us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1226042 | USD | |
| us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
685208 | USD | |
| CY2013Q2 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.08 | pure |
| us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.08 | pure | |
| CY2013Q1 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.08 | pure |
| CY2013Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
281000 | USD |
| CY2012Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
178775 | USD |
| us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
7450000 | shares | |
| us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
6852088 | shares | |
| CY2013Q2 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
8784000 | shares |
| CY2013Q1 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
9739912 | shares |
| us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
160105 | USD | |
| us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
48912 | USD | |
| CY2013Q3 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.125 | |
| CY2013Q2 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.125 | |
| CY2013Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
745000 | USD |
| CY2013Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1098000 | USD |
| CY2012Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
685208 | USD |
| us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.08 | pure | |
| CY2013Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
435686 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
USD | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
47573 | USD | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
32121 | USD | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2551594 | USD | |
| CY2013Q3 | us-gaap |
Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
|
104469233 | USD |
| CY2012Q4 | us-gaap |
Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
|
98732460 | USD |
| us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
USD | ||
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | ||
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | ||
| CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
36915 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
USD | ||
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
24253 | USD | |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y6M18D | ||
| CY2013Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
104000 | USD |
| us-gaap |
Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
|
0.10 | ||
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | ||
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | ||
| CY2013Q3 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | |
| CY2012Q3 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | |
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
21663 | USD | |
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
USD | ||
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
USD | ||
| CY2013Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
USD | |
| CY2012Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
USD | |
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
216617 | USD | |
| us-gaap |
Gross Profit
GrossProfit
|
469816 | USD | |
| us-gaap |
Gross Profit
GrossProfit
|
477513 | USD | |
| CY2013Q3 | us-gaap |
Gross Profit
GrossProfit
|
260069 | USD |
| CY2012Q3 | us-gaap |
Gross Profit
GrossProfit
|
463497 | USD |
| us-gaap |
Gross Profit
GrossProfit
|
2015404 | USD | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4008720 | USD | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-3125886 | USD | |
| CY2013Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-964789 | USD |
| CY2012Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-651980 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-92758219 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | ||
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | ||
| CY2013Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2012Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-939074 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
38989 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
84114 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3144793 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
142094 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
15863 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
193873 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
435686 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
USD | ||
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
435686 | USD | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
USD | ||
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
USD | ||
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
1823103 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-319830 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
194756 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
362542 | USD | |
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
580000 | USD | |
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
USD | ||
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
580000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-9442 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-880 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
37511 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-318438 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
72644 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
429203 | USD | |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | USD | |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
235762 | USD | |
| us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-299805 | USD | |
| us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-447978 | USD | |
| CY2013Q3 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-84946 | USD |
| CY2012Q3 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-50801 | USD |
| us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-7601355 | USD | |
| us-gaap |
Interest Paid
InterestPaid
|
USD | ||
| us-gaap |
Interest Paid
InterestPaid
|
USD | ||
| us-gaap |
Interest Paid
InterestPaid
|
590189 | USD | |
| CY2013Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
211000 | USD |
| CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
439000 | USD |
| CY2013Q3 | us-gaap |
Inventory Net
InventoryNet
|
362542 | USD |
| CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
682372 | USD |
| CY2013Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
26000 | USD |
| CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
49000 | USD |
| CY2013Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
125000 | USD |
| CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
195000 | USD |
| us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
65468 | USD | |
| us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
USD | ||
| us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
95468 | USD | |
| CY2013Q3 | us-gaap |
Liabilities
Liabilities
|
3065719 | USD |
| CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
2076736 | USD |
| CY2013Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4039006 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3339408 | USD |
| CY2013Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3065719 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2076736 | USD |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3022687 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3750000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
75477550 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-52137 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-20957 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4571138 | USD | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-104469233 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2386815 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2854564 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-68580671 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-4008720 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-3125886 | USD | |
| CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-964789 | USD |
| CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-651980 | USD |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-91819145 | USD | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-5736773 | USD | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4996732 | USD | |
| CY2013Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1489937 | USD |
| CY2012Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1281705 | USD |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-299805 | USD | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-447978 | USD | |
| CY2013Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-84946 | USD |
| CY2012Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-50801 | USD |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7724570 | USD | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
4178731 | USD | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
3155421 | USD | |
| CY2013Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1139912 | USD |
| CY2012Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1064676 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
87049053 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3708915 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2677908 | USD | |
| CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-879843 | USD |
| CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-601179 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-85033649 | USD | |
| us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
USD | ||
| us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
USD | ||
| us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
74938 | USD | |
| CY2013Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
251409 | USD |
| CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
254220 | USD |
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
36915 | USD | |
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
USD | ||
| CY2013Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
40184 | USD |
| CY2012Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
USD | |
| us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
USD | ||
| us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
USD | ||
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
24253 | USD | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
36915 | USD | |
| us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
USD | ||
| us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
USD | ||
| us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
361496 | USD | |
| us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
USD | ||
| us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
USD | ||
| CY2013Q3 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
USD | |
| CY2012Q3 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
USD | |
| us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
361495 | USD | |
| us-gaap |
Other Operating Income
OtherOperatingIncome
|
USD | ||
| us-gaap |
Other Operating Income
OtherOperatingIncome
|
USD | ||
| CY2013Q3 | us-gaap |
Other Operating Income
OtherOperatingIncome
|
USD | |
| CY2012Q3 | us-gaap |
Other Operating Income
OtherOperatingIncome
|
USD | |
| us-gaap |
Other Operating Income
OtherOperatingIncome
|
6055483 | USD | |
| us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
3147 | USD | |
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
18861 | USD | |
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
20957 | USD | |
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
517375 | USD | |
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
USD | ||
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
USD | ||
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
393607 | USD | |
| us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
USD | ||
| us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
USD | ||
| us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
1632168 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
33276 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
USD | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2454086 | USD | |
| us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1728053 | USD | |
| us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
1870846 | USD | |
| CY2013Q3 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
525148 | USD |
| CY2012Q3 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
629725 | USD |
| us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
12650088 | USD | |
| CY2013Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1717 | USD |
| CY2012Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1594 | USD |
| CY2013Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
737655 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
476093 | USD |
| us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong> </strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Reclassifications</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> Certain items for the periods ended September 30, 2012 have been reclassified to conform to the presentation at September 30, 2013. There was no change in net income as a result of these reclassifications.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <!--EndFragment--></div> </div> | ||
| us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
1599967 | USD | |
| us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
3050000 | USD | |
| us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
51671278 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | ||
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | ||
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
400490 | USD | |
| us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
USD | ||
| us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
USD | ||
| us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
9579040 | USD | |
| us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
1263000 | USD | |
| us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
700000 | USD | |
| us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
13151881 | USD | |
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
USD | ||
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
USD | ||
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
499395 | USD | |
| us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
USD | ||
| us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
USD | ||
| us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
393607 | USD | |
| us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
USD | ||
| us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
USD | ||
| us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
32491 | USD | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
20194 | USD | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
USD | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
35940 | USD | |
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
139526 | USD | |
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | ||
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
139526 | USD | |
| us-gaap |
Professional Fees
ProfessionalFees
|
570465 | USD | |
| us-gaap |
Professional Fees
ProfessionalFees
|
385612 | USD | |
| CY2013Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
157926 | USD |
| CY2012Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
150785 | USD |
| us-gaap |
Professional Fees
ProfessionalFees
|
9155600 | USD | |
| CY2013Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
143533 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
145600 | USD |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
USD | ||
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
USD | ||
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
255882 | USD | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1706498 | USD | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1854407 | USD | |
| CY2013Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
294198 | USD |
| CY2012Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
554266 | USD |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
55635957 | USD | |
| us-gaap |
Revenue From Grants
RevenueFromGrants
|
1035877 | USD | |
| us-gaap |
Revenue From Grants
RevenueFromGrants
|
675000 | USD | |
| CY2013Q3 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
677131 | USD |
| CY2012Q3 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
591667 | USD |
| us-gaap |
Revenue From Grants
RevenueFromGrants
|
3227684 | USD | |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
507628 | USD | |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
63614 | USD | |
| CY2013Q3 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
203561 | USD |
| CY2012Q3 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
13679 | USD |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
695280 | USD | |
| us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1543505 | USD | |
| us-gaap |
Sales Revenue Net
SalesRevenueNet
|
738614 | USD | |
| CY2013Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
880692 | USD |
| CY2012Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
605346 | USD |
| us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3922964 | USD | |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1901768 | USD | |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
915402 | USD | |
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1599967 | USD | |
| us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
20194 | USD | |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
300105 | USD | |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
16964 | USD | |
| us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
2868293 | USD | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.12 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.11 | ||
| CY2013Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
687788 | USD |
| CY2012Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
359625 | USD |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
28312979 | USD | |
| us-gaap |
Service Management Costs
ServiceManagementCosts
|
USD | ||
| us-gaap |
Service Management Costs
ServiceManagementCosts
|
USD | ||
| us-gaap |
Service Management Costs
ServiceManagementCosts
|
1334285 | USD | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.28 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.019 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.008 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
9402 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
2.01 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
13985000 | shares | |
| CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
47851477 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
36667616 | shares |
| CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.21 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.23 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.04 | ||
| CY2013Q3 | us-gaap |
Shares Held In Employee Stock Option Plan Allocated
SharesHeldInEmployeeStockOptionPlanAllocated
|
22750000 | shares |
| CY2013Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13610228 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11625145 | USD |
| us-gaap |
Stock Issued1
StockIssued1
|
34034 | USD | |
| us-gaap |
Stock Issued1
StockIssued1
|
236565 | USD | |
| us-gaap |
Stock Issued1
StockIssued1
|
617520 | USD | |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
556737 | shares | |
| us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
20386 | USD | |
| us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
65468 | USD | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong> </strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Use of Estimates</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities. Actual results could differ from these estimates. Significant estimates in these financials are the valuation of options granted, the valuation of preferred shares issued as stock dividends and valuation methods used in determining any debt discount associated with convertible securities.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong> </strong></p> <!--EndFragment--></div> </div> | ||
| CY2013Q3 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
171012 | USD |
| CY2012Q3 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
38788 | USD |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
232426316 | shares | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
193383650 | shares | |
| CY2013Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
242512486 | shares |
| CY2012Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
204438894 | shares |
